Pivotal Phase III SUNMO study demonstrated an 11.5 month median progression-free survival – three times longer than R-GemOx – ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of ...

A long-term study published in the June 2025 issue of Journal of Clinical Oncology; researchers conducted a retrospective ...

Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...

Explore the science of creatine's effects on muscle growth and recovery. Discover how this go-to supplement can enhance your ...

H. Lundbeck A/S (Lundbeck) today announced the full results from the SUNRISE trial, a randomized, placebo-controlled trial designed to evaluate the efficacy and safety of eptinezumab versus placebo in ...

Results from the study continue to demonstrate the transformative potential of zimislecel with consistent and durable patient benefit – ...

An Iran Deal in Two Weeks? Hard to Achieve, Even if Trump Really Wants One. Negotiating with Tehran is time-consuming, and it’s unclear whether President Trump’s 14-day clock is more than a ...

Despite representing 18% of the global population, Africa accounts for less than 2.5% of global clinical trials. This ...

Two centuries after his downfall, Napoleon remains both revered and controversial in France — but above all, unavoidable.

New studies reveal individuals with low LDL cholesterol have a significantly reduced risk of developing Alzheimer’s ...